Human data are extremely limited and consist only of a small number of low-quality or small-sample studies
FIN56 is one ferroptosis inducer derived from CIL56, which is capable to induce cell death without activating caspases 3/7 (Shimada et al., 2016)
and 3-numerous confluent changes subcategorized into: (a) the hemorrhagic zone, (b) edema, (c) the loss of neurons, (d) vacuoles, and (e) the loss of spinal column tracts [3]
In a BPC-157 and TB-500 stack, it is common to keep the BPC-157 dose at the standard 250-500 mcg range, as its action is highly localized, but reduce the TB-500 dose to the lower end of the range (e.g., 2.5 mg per week) for systemic support
It promotes angiogenesisthe formation of new blood vesselswhich is crucial for delivering oxygen and nutrients to damaged tissues